US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 4.980
  • +0.020+0.40%
Close Sep 27 16:00 ET
  • 4.980
  • 0.0000.00%
Post 20:02 ET
421.43MMarket Cap-1922P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.71M
6.69M
+3.98M
Beat Est.
+29.51%
+219.73%
+146.89%
EPS
-0.68
-0.59
+0.09
Beat Est.
+21.61%
+32.18%
+13.48%
Analyst Rating
Strong Buy

Aug 31, 2024

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.644M--
--2024/Q3-- / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
--2024/Q15.695M / 2.250M--
--2023/Q45.143M / 1.167M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.644M--
--2024/Q3-- / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
--2024/Q15.695M / 2.250M--
--2023/Q45.143M / 1.167M--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

  • Verve Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:34 ET

  • Verve Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 07:33 ET

  • Verve Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 08:05 ET

  • Verve Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 07:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data